What Salvia does

Salvia GmbH is a first-generation single Family Office founded in 2014 by Helmut Jeggle, headquartered in Holzkirchen near Munich, Germany, and registered as Salvia GmbH in the Munich Commercial Register (HRB 214305). The firm originally operated as a traditional angel investor and has since evolved into an entrepreneurial venture capital investor focused on innovative startups in the Deep Tech and Science sectors, including biotechnology, quantum computing, artificial intelligence, battery technology, advanced manufacturing, and drone delivery.

Salvia operates two distinct investment services: Angel Investments targeting pre-seed and seed-stage startups, and Venture Capital Investments supporting growth-stage companies through equity rounds. Portfolio companies include Bambusa Therapeutics (Series A, 2025), Group14 Technologies (Series C, 2022), IQM Quantum Computers (Series A2, 2022), Wingcopter (Series A extension, 2022), ONE DATA/ONE LOGIC (Series B, 2021 led by Salvia), OQmented (Seed extension, 2021), Aldevron (acquired by Danaher for $9.6B in 2021), tonies/Boxine (SPAC 2021), and BioNTech (IPO 2019). The firm provides portfolio companies with capital, strategic know-how, and access to an extensive global network built through founder Helmut Jeggle's involvement as BioNTech co-founder and Chairman of its Supervisory Board.

The business model is investment-return-driven rather than fee-driven: Salvia does not publicly disclose pricing, management fees, or financial statements. The firm operates with a small team (1-10 employees, four named investment professionals) and uses personal networks, board participation, and partnerships with co-investors such as Vsquared Ventures, Bayern Kapital, MIG Fonds, and RA Capital Management as its primary deal-sourcing channels. Recent strategic positioning includes the February 2026 announcement that portfolio company IQM will become the first publicly listed European quantum computing company through a SPAC merger with Real Asset Acquisition Corp.

Name

Salvia

Legal name

Salvia GmbH

Website

https://salvia.de

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Salvia GmbH is a first-generation single Family Office founded in 2014 in Holzkirchen, Germany, providing capital, know-how, and global network access to innovative Deep Tech and Science startups across biotechnology, quantum computing, AI, battery technology, and drone delivery sectors through angel and venture capital investments.

Ownership category

akta.pro rank

Product category

Venture Capital / Family Office Investment Services

NAICS

Portfolio Management and Investment Advice (52394), Offices of Other Holding Companies (551112), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest) (FSAAADAH)

akta.pro secondary industries

Family Office Services (Single & Multi-Family Office) (FSABADAF), Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Venture capital investing
• Family office
• Deep tech investments
• Early-stage funding
• Science startups

Headquarters

HQ city

Holzkirchen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Investment Returns: Generates returns through equity investments in innovative startups and growth-stage companies. Returns realized through exits (IPO, M&A, SPAC) and ongoing portfolio value appreciation. Focus on long-term value creation in Deep Tech and Science sectors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Salvia GmbH is a first-generation single Family Office that invests equity capital in innovative Deep Tech and Science startups, from early-stage (angel) investments through venture-stage growth rounds. The firm provides portfolio companies with capital, strategic know-how, and access to its global network, with a long-term orientation toward building sustainable enterprises. Salvia operates two distinct investment services: Angel Investments in pre-seed/seed phases and Venture Capital Investments for growth-stage companies.

Product overview

Salvia GmbH is a first-generation single Family Office and venture capital investor founded in 2014 by Helmut Jeggle. The company operates two distinct investment services: Venture Capital Investments for growth-stage companies and Angel Investments for early-stage startups. Salvia's investment focus spans innovative Deep Tech and Science companies across sectors including biotechnology, quantum computing, artificial intelligence, battery technology, and advanced manufacturing. The company provides capital, know-how, and network access to portfolio companies with the goal of creating long-term, opportunistic, and healthy values.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investments

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Earlybird Venture Capital: One of Europe's longest-standing deep tech and technology VCs, investing across similar stages and sectors as Salvia. Comparable in backing European science-driven founders from early to growth stages.
• Vsquared Ventures: Munich-based deep tech VC firm that has co-invested with Salvia in Group14's $400M Series C and OQmented's seed extension. Operates in the same European deep tech segment with comparable check sizes and sector focus (quantum, biotech, climate).
• Creathor Ventures: German/European early-stage deep tech and tech VC investing across similar stages and sectors (life sciences, industrial tech, digital). Comparable fund size and stage focus to Salvia's VC arm.
• Bayern Kapital: Bavarian regional VC that co-invested with Salvia in IQM's €128M Series A2. Targets innovative tech companies in Bavaria with similar deep tech orientation, making it a directly comparable regional peer.
• HV Capital: German venture and growth investor with comparable focus on technology and science-driven businesses. Operates with similar multi-stage approach across European deep tech deals.
• MIG Fonds: Munich-based VC that participated alongside Salvia in IQM and similar deep tech rounds. Focused on German technology and life sciences ventures with comparable stage range.

Emerging players

• APEX Ventures: Austrian/European deep tech seed and early-stage VC active in similar frontier technology sectors (quantum, biotech, AI). Comparable in stage and geography though smaller and earlier-stage focused.

Regional players

• Santander InnoVentures: Family-office style strategic venture vehicle from Santander Group that invests in deep tech and fintech across Europe. Comparable as a corporate/family-backed venture investor but focused on different regional and sector priorities.

Broad incumbents

• EQT Ventures: European venture arm of EQT with deep tech and growth-stage mandates. A broader incumbent with significantly more capital and a wider portfolio overlap with Salvia's late-stage deep tech bets.
• Index Ventures: Large European-headquartered VC that frequently backs the same deep tech and life sciences companies as Salvia. A broader incumbent with overlapping portfolio companies but much larger AUM and global scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salvia